05Aug
Defying gravity: US M&A H1 2019: Pharma chases innovation through deals
The need to replenish intellectual property has pushed the pharma industry to the highest-performing sector by M&A value. In the pharmaceuticals, medical and biotech sector, deal value in the first half of the year was up 142 percent to US$172...
By:
White & Case LLP
Related
The First Circuit recently denied a corporation’s numerous arguments seeking to vacate an arbitrati...
Read More >
One of the ways to operationalize compliance and to drive it into the DNA of an organization is thro...
Read More >
New Jersey has enacted a new law prohibiting employers from seeking or relying on job applicants’ s...
Read More >
Two federal courts have struck down the U.S. Department of Health and Human Services’ (HHS) “Consc...
Read More >
On September 5, 2019, the Washington Supreme Court held that non-agricultural employees do not have ...
Read More >
• Following the financial crisis, nonbank lenders looking to carve out new, profitable niches—espe...
Read More >